1-Year Clinical Performance of COMBO Stent Versus Xience Stent in All-Comers Patients With Coronary Artery Disease

JACC Cardiovasc Interv. 2018 Jan 8;11(1):102-103. doi: 10.1016/j.jcin.2017.10.006.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Aged
  • Antibodies / administration & dosage*
  • Antibodies / adverse effects
  • Antibodies / immunology
  • Antigens, CD34 / immunology
  • Coronary Artery Disease / diagnostic imaging
  • Coronary Artery Disease / immunology
  • Coronary Artery Disease / mortality
  • Coronary Artery Disease / surgery*
  • Drug-Eluting Stents*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Percutaneous Coronary Intervention / adverse effects
  • Percutaneous Coronary Intervention / instrumentation*
  • Percutaneous Coronary Intervention / mortality
  • Postoperative Complications / mortality
  • Prosthesis Design
  • Prosthesis Failure
  • Randomized Controlled Trials as Topic
  • Registries
  • Risk Assessment
  • Risk Factors
  • Sirolimus / administration & dosage*
  • Sirolimus / adverse effects
  • Time Factors
  • Treatment Outcome

Substances

  • Antibodies
  • Antigens, CD34
  • Sirolimus